Page last updated: 2024-09-05

n-(4-(2-chloroethylmethylamino)-2-butynyl)-2-pyrrolidone and oxotremorine m

n-(4-(2-chloroethylmethylamino)-2-butynyl)-2-pyrrolidone has been researched along with oxotremorine m in 1 studies

Compound Research Comparison

Studies
(n-(4-(2-chloroethylmethylamino)-2-butynyl)-2-pyrrolidone)
Trials
(n-(4-(2-chloroethylmethylamino)-2-butynyl)-2-pyrrolidone)
Recent Studies (post-2010)
(n-(4-(2-chloroethylmethylamino)-2-butynyl)-2-pyrrolidone)
Studies
(oxotremorine m)
Trials
(oxotremorine m)
Recent Studies (post-2010) (oxotremorine m)
1500186035

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ehlert, FJ1

Other Studies

1 other study(ies) available for n-(4-(2-chloroethylmethylamino)-2-butynyl)-2-pyrrolidone and oxotremorine m

ArticleYear
Effects of an alkylating derivative of oxotremorine (BM 123A) on heart rate, muscarinic receptors and adenylate cyclase activity in the rabbit myocardium.
    The Journal of pharmacology and experimental therapeutics, 1987, Volume: 241, Issue:3

    Topics: Adenylyl Cyclases; Animals; Aziridines; Azirines; Guanosine Triphosphate; Heart Rate; Male; Mathematics; Myocardium; N-Methylscopolamine; Oxotremorine; Pyrrolidinones; Rabbits; Receptors, Muscarinic; Scopolamine Derivatives

1987